The board of directors of Lepu Biopharma Co., Ltd. announced that with effect from 15 August 2022, the address of the principal place of business in Hong Kong of the company will be relocated from Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong to 5/F, Manulife Place, 348 Kwun Tong Road, Kowloon, Hong Kong.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.04 HKD | +7.23% | +16.94% | +19.71% |
04-12 | Keymed Biosciences Advances Solid Tumors Drug With First Patient Study | MT |
03-27 | Lepu Biopharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.71% | 1.07B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 2157 Stock
- News Lepu Biopharma Co., Ltd.
- Lepu Biopharma Co., Ltd. Change of Address of Principal Place of Business in Hong Kong